Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Macter Pharma
|
Zoledronic Acid 4mg/5ml
|
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
Sanofi |
Benzoyl Metronidazole 120ml |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Aqvida |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Pfizer
|
Cisplatin 50mg
|
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Pfizer |
Amlodipine besylate 5mg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Fresenius kabi |
Cytarabine 500mg/50ml |
Content | Zoledronic acid is used to treat high levels of calcium in the blood that may be caused by certain types of cancer.
| "Metronidazole Benzoate is indicated for the treatment of infections caused by a wide range of anaerobic, protozoan and bacteroid bacteria, including trichomoniasis, amebiasis, vaginosis and gingivitis."
| Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. | Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. | Amlodipine is an oral antihypertensive medicine that belongs to the class of calcium channel blockers. It works by relaxing the blood vessels to allow easy flow of blood
| Cytarabine is a medication used in the management and treatment of leukemias and lymphomas. It belongs to the antimetabolic group of medications. This activity reviews the indications, action, and contraindications for cytarabine as a valuable agent in treating acute myeloid leukemia (and other leukemias. |
Reviews
There are no reviews yet.